PT-141 vs Melanotan II

TL;DR

• PT-141 (bremelanotide) is selective for the MC4R receptor. Studied primarily for sexual function. FDA-approved for hypoactive sexual desire disorder (HSDD).
• Melanotan II is non-selective. It activates MC1R (skin pigmentation), MC3R, MC4R (sexual function and appetite), and others. Not FDA-approved.
• The shorthand: PT-141 is the targeted, approved option for sexual function. Melanotan II is the broad-spectrum, unapproved option that also produces tanning.

If you only remember one thing: PT-141 was specifically engineered to keep MT-II's sexual-function effects while dropping its pigmentation and appetite effects.

The headline difference, in one sentence

Melanotan II hits every melanocortin receptor. PT-141 was redesigned to hit just the one that matters for sexual function — and skip everything else.

What each one is

PT-141 literally exists because researchers wanted MT-II's sexual-function effects without MT-II's pigmentation and appetite side effects. They modified the molecule to drop the unwanted activity.

Pick PT-141 if...

• The research target is sexual desire or arousal — PT-141 is the only one of the two with FDA approval for this.
• You want minimal side effects outside the target system — no tanning, no significant appetite changes.
• You want a compound with clinical trial data and a marketed product behind it.
• The research is on central nervous system mechanisms of sexual function rather than peripheral hormonal effects.

Pick Melanotan II if...

• The research target is pigmentation / tanning — MT-II is the more-studied option here.
• You're researching multi-receptor melanocortin biology and want broad MC activity.
• You're aware of the broader side-effect profile and consider the additional effects acceptable for the research.

Honest note: Melanotan II is widely sold for cosmetic tanning purposes, but this is unregulated and unapproved use. Mole changes, dysplastic nevi reports, and rare more serious adverse events have appeared in case reports.

What "selective for MC4R" actually means

Melanocortin receptors are a family. Each one does different things:

• MC1R: skin pigmentation (melanocytes producing melanin)
• MC2R: adrenal cortex / cortisol
• MC3R: energy homeostasis
• MC4R: appetite + sexual function (in CNS)
• MC5R: exocrine gland function

Melanotan II hits MC1R, MC3R, MC4R, MC5R. So you get tanning (MC1R), appetite suppression (MC4R), sexual effects (MC4R), and more. The side effects aren't side effects — they're predictable receptor activations.

PT-141 was engineered to be MC4R-selective. So you get the sexual-function effect and lose the tanning, the major appetite suppression, and most of the receptor noise.

Honest tradeoffs

• Spontaneous erections / arousal: both compounds can produce this in research subjects, often unwanted at inopportune times. PT-141 has been more carefully dose-titrated in trials.
• Nausea: both produce GI side effects, particularly at higher doses. Generally most pronounced in the first 1–2 hours after dosing.
• Mole darkening: a hallmark of MT-II that PT-141 mostly avoids. People with significant nevi or family history of melanoma should approach MT-II with extra caution.
• Cardiovascular: PT-141 transiently elevates blood pressure. This is one reason its FDA label restricts use in cardiovascular disease populations.
• MT-II tanning is real but slow: it takes weeks of dosing plus actual UV exposure to produce visible darkening. It's not a "magic tan in a syringe."

Quick decision shortcut

Where to read more

• Full breakdown of PT-141 — mechanism, dosing, FDA approval context.
• Full breakdown of Melanotan II — broad melanocortin activity and side-effect profile.
• The first-generation tanning peptide: Melanotan I.

Important context

PT-141 (Vyleesi) is FDA-approved as a prescription medication for HSDD. Melanotan II is not approved for any indication. Both can produce significant side effects. People with personal or family history of melanoma, dysplastic nevi, or cardiovascular disease should approach either with particular caution. Nothing on this page is medical advice.